Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Neoplasms, Recurrent”

956 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 956 results

Not applicableUnknownNCT04859543
What this trial is testing

Pediatric Prospective Personalized Immune and Target Identification Trial

Who this might be right for
Central Nervous System NeoplasmsPediatric CancerGEN1 Gene Mutation+1 more
Masaryk University 80
Early research (Phase 1)Study completedNCT03087591
What this trial is testing

APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Solid NeoplasmRecurrent Colorectal Carcinoma+9 more
Wake Forest University Health Sciences 11
Testing effectiveness (Phase 2)Study completedNCT00007982
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

Who this might be right for
Brain and Central Nervous System TumorsHead and Neck CancerLymphoma
Herbert Irving Comprehensive Cancer Center 30
Early research (Phase 1)Active Not RecruitingNCT05768880
What this trial is testing

Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors

Who this might be right for
Diffuse Intrinsic Pontine GliomaDiffuse Midline GliomaRecurrent CNS Tumor, Adult+2 more
Seattle Children's Hospital 72
Testing effectiveness (Phase 2)Study completedNCT00615927
What this trial is testing

Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)

Who this might be right for
GlioblastomaGliosarcoma
Duke University 64
Testing effectiveness (Phase 2)Ended earlyNCT00003476
What this trial is testing

Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors

Who this might be right for
Childhood Brain Tumor
Burzynski Research Institute 8
Testing effectiveness (Phase 2)Study completedNCT00504660
What this trial is testing

6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients

Who this might be right for
Anaplastic Glioma of BrainGlioblastoma MultiformeBrain Cancer
M.D. Anderson Cancer Center 75
Testing effectiveness (Phase 2)Study completedNCT00058123
What this trial is testing

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 55
Testing effectiveness (Phase 2)Study completedNCT00404248
What this trial is testing

Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Early research (Phase 1)Ended earlyNCT01378481
What this trial is testing

High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00038441
What this trial is testing

Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas

Who this might be right for
GliomaBrain Neoplasms
M.D. Anderson Cancer Center 39
Large-scale testing (Phase 3)Study completedNCT00118222
What this trial is testing

High Light and Low Light Dose PDT in Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Case Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Early research (Phase 1)Study completedNCT02197169
What this trial is testing

DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors

Who this might be right for
Glioblastoma or Gliosarcoma
DNAtrix, Inc. 37
Not applicableLooking for participantsNCT05504772
What this trial is testing

Precision Medicine for Every Child With Cancer

Who this might be right for
Childhood CancerChildhood Solid TumorChildhood Brain Tumor+3 more
Australian & New Zealand Children's Haematology/Oncology Group 3,500
Early research (Phase 1)Study completedNCT00077454
What this trial is testing

Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Previously Treated Childhood RhabdomyosarcomaRecurrent Childhood Brain TumorRecurrent Childhood Cerebellar Astrocytoma+9 more
National Cancer Institute (NCI) 95
Early research (Phase 1)Looking for participantsNCT05609994
What this trial is testing

ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas

Who this might be right for
Low Grade Glioma of Brain
Katy Peters, MD, PhD 48
Early research (Phase 1)Study completedNCT00036894
What this trial is testing

CC-5013 in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00087061
What this trial is testing

Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01472731
What this trial is testing

Safety and Imaging Study of GC1008 in Glioma

Who this might be right for
Primary Brain Tumors
University Medical Center Groningen 12
Load More Results